Tetra Pharm Technologies ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 14.8% 2.8% 5.3% 5.0%  
Credit score (0-100)  0 14 57 42 43  
Credit rating  N/A BB BBB BBB BBB  
Credit limit (kDKK)  0.0 -0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 -926 3,208 0.0 585  
EBITDA  0.0 -1,072 -327 -20,938 -38,817  
EBIT  0.0 -1,145 -414 -20,938 -38,817  
Pre-tax profit (PTP)  0.0 -1,151.1 -501.9 -20,996.8 -38,400.9  
Net earnings  0.0 -897.9 305.6 -19,564.2 -32,946.9  
Pre-tax profit without non-rec. items  0.0 -1,151 -502 -20,997 -38,401  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 338 719 3,584 14,175  
Shareholders equity total  0.0 -856 13,787 65,035 32,088  
Interest-bearing liabilities  0.0 1,733 2,833 0.0 0.0  
Balance sheet total (assets)  0.0 912 18,288 68,781 34,580  

Net Debt  0.0 1,733 -2,366 -60,917 -8,928  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 -926 3,208 0.0 585  
Gross profit growth  0.0% 0.0% 0.0% -100.0% 0.0%  
Employees  0 0 0 15 24  
Employee growth %  0.0% 0.0% 0.0% 0.0% 60.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 912 18,288 68,781 34,580  
Balance sheet change%  0.0% 0.0% 1,905.0% 276.1% -49.7%  
Added value  0.0 -1,072.4 -326.6 -20,850.7 -38,816.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 265 3,462 -303 10,591  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 123.6% -12.9% 0.0% -6,638.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% -64.7% -4.1% -48.1% -74.3%  
ROI %  0.0% -37.1% -4.1% -50.9% -79.1%  
ROE %  0.0% -98.4% 4.2% -49.6% -67.8%  

Solidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% -48.4% 75.4% 94.6% 92.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -161.6% 724.3% 290.9% 23.0%  
Gearing %  0.0% -202.4% 20.5% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.7% 3.8% 4.1% 0.0%  

Liquidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 1.1 0.0 17.2 7.7  
Current Ratio  0.0 1.1 0.0 17.2 7.7  
Cash and cash equivalent  0.0 0.0 5,198.4 60,916.5 8,927.6  

Capital use efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 53.1 9,619.3 60,534.4 16,780.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 -1,390 -1,617  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 -1,396 -1,617  
EBIT / employee  0 0 0 -1,396 -1,617  
Net earnings / employee  0 0 0 -1,304 -1,373